DMSB01

· Samyang Biopharmaceuticals Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DMSB01, covering 2024-05-13 to 2024-05-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study Comparing DMSB01 and Rejuran® for Temporary Crow's Feet Lines Improvement [NA]